BCM
RGLS

Bourgeon Capital Management’s Regulus Therapeutics RGLS Stock Holding History

Bourgeon Capital Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32
Closed – – 304
2020
Q4 		$0 Hold
32
– – ﹤0.01% 317
2020
Q3 		$0 Hold
32
– – ﹤0.01% 315
2020
Q2 		$0 Hold
32
– – ﹤0.01% 271
2020
Q1 		$0 Hold
32
– – ﹤0.01% 272
2019
Q4 		$0 Hold
32
– – ﹤0.01% 243
2019
Q3 		$0 Buy
+32
New +$261 ﹤0.01% 239
2018
Q3 		– Sell
-111
Closed -$9K – 77
2018
Q2 		$9K Hold
111
– – ﹤0.01% 73
2018
Q1 		$10K Sell
111
-479
-81% -$64.1K 0.01% 74
2017
Q4 		$74K Buy
590
+250
+74% +$31.6K 0.04% 86
2017
Q3 		$51K Buy
+340
New +$42.8K 0.03% 88
2017
Q1 		– Sell
-199
Closed -$54K – 100
2016
Q4 		$54K Sell
199
-178
-47% -$57.9K 0.03% 92
2016
Q3 		$149K Sell
377
-212
-36% -$87.2K 0.1% 86
2016
Q2 		$204K Buy
589
+211
+56% +$151K 0.13% 81
2016
Q1 		$314K Buy
378
+122
+48% +$97.1K 0.21% 69
2015
Q4 		$268K Sell
256
-119
-32% -$119K 0.17% 72
2015
Q3 		$294K Buy
375
+206
+122% +$211K 0.21% 76
2015
Q2 		$222K Hold
169
– – 0.13% 98
2015
Q1 		$343K Buy
+169
New +$367K 0.21% 83

Other funds holding RGLS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bourgeon Capital Management's RGLS Position: Q1 2021 in Review

Bourgeon Capital Management sold out of Regulus Therapeutics (RGLS) in Q1 2021, closing a stake of 32 shares.

Bourgeon Capital Management first reported a position in RGLS in Q1 2015 and held it in 18 quarters. The position peaked at $343K in Q1 2015. 44 funds tracked by Wall St. Rank hold RGLS as of Q1 2021.

  • Bourgeon Capital Management reported no remaining Regulus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Bourgeon Capital Management sold 32 Regulus Therapeutics shares in Q1 2021.
  • Bourgeon Capital Management first reported a position in Regulus Therapeutics in Q1 2015 and held it in 18 quarters.
  • Bourgeon Capital Management's Regulus Therapeutics position peaked at $343K in Q1 2015.
  • 44 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2021.

Based on Bourgeon Capital Management's 13F filing for Q1 2021, filed 13 May 2021.